The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

JMP Securities analyst reaffirmed a positive outlook on Larimar Therapeutics (NASDAQ:LRMR), maintaining a Market Outperform ...

Precigen, Inc. (NASDAQ:PGEN), a biotechnology company specializing in gene and cell therapies with a market capitalization of $398.3 million, is on the cusp of a significant transformation as it ...

The firm said it has received positive feedback from the FDA on the design of a Phase III trial of ELI-002 in KRAS-mutant pancreatic cancer.

The phase 3 REGAL trial of galinpepimut-S in acute myeloid leukemia can proceed without modifications, based on findings from ...

Liability and injury: Changes to the existing liability protections for certain vaccine makers and modifications to the list ...

Heart failure resulting from treatments for non-cardiac medical conditions presents a significant challenge in clinical ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

We assess each application individually and decide whether the content of your application provides evidence that you’re prepared to progress onto the course you’re applying for. You can review the ...

Birthright citizenship CNN layoffs Today’s horoscope Weekend activities NYC education panel pushes back on Trump order to allow ICE in schools with deportations looming ...